Eligibility Matcher
Select your organization type below to see only the grants you qualify for — sorted by soonest deadline.
Native American tribal organizations (other)Nonprofits having 501(c)(3) statusNonprofits without 501(c)(3) statusPrivate institutions of higher educationIndividualsFor-profit organizationsSmall businessesOthersUnrestrictedState governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic/State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities
403 grants for Special district governments
Sorted by deadline (soonest first)
Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)
HHS-NIH11 · RFA-AI-27-005
Closes Nov 10, 2026
Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
HHS-NIH11 · RFA-AI-27-002
Closes Nov 10, 2026
Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
HHS-NIH11 · RFA-AG-27-010
Closes Nov 10, 2026
Pilot Projects to Enhance the Human Virome Program (R03 Clinical Trials Not Allowed)
HHS-NIH11 · RFA-RM-27-024
Closes Nov 10, 2026
NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)
HHS-NIH11 · PAR-25-271
Closes Nov 13, 2026
NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
HHS-NIH11 · PAR-25-269
Closes Nov 13, 2026
NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
HHS-NIH11 · PAR-24-089
Closes Nov 13, 2026
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
HHS-NIH11 · PAR-25-270
Closes Nov 13, 2026
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
HHS-NIH11 · PAR-25-370
Closes Nov 16, 2026
Fiscal Year 2026 Wildlife Crossings Pilot Program
DOT-FHWA · FHWA-WCPP-26-002
Closes Nov 16, 2026
OJJDP FY 2026 Emergency Planning for Juvenile Justice Residential Facilities
USDOJ-OJP-OJJDP · O-OJJDP-2026-172735
Closes Nov 16, 2026
NIJ FY 2026 Evaluation of the Effectiveness of the Bureau of Justice Assistance (BJA) Byrne State Crisis Intervention Program (SCIP)
USDOJ-OJP-NIJ · O-NIJ-2026-172798
Closes Nov 16, 2026
OJJDP FY 2026 Strategies to Support Children Exposed to Violence
USDOJ-OJP-OJJDP · O-OJJDP-2026-172752
Closes Nov 16, 2026
NIJ FY 2026 Research and Evaluation on Human Trafficking
USDOJ-OJP-NIJ · O-NIJ-2026-172799
Closes Nov 16, 2026
NIJ FY 2026 Research and Evaluation on Justice System Responses to Illegal Immigration
USDOJ-OJP-NIJ · O-NIJ-2026-172800
Closes Nov 16, 2026
NIJ FY 2026 Crime and Justice Research
USDOJ-OJP-NIJ · O-NIJ-2026-172801
Closes Nov 16, 2026
Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
HHS-NIH11 · PAR-25-274
Closes Nov 17, 2026
Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
HHS-NIH11 · PAR-25-268
Closes Nov 17, 2026
NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)
HHS-NIH11 · PAR-25-267
Closes Nov 17, 2026
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
HHS-NIH11 · PAR-25-158
Closes Nov 17, 2026
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
HHS-NIH11 · PAR-25-096
Closes Nov 17, 2026
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
HHS-NIH11 · PAR-25-371
Closes Nov 18, 2026
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
HHS-NIH11 · PAR-25-369
Closes Nov 18, 2026
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)
HHS-NIH11 · PAR-25-052
Closes Nov 19, 2026
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
HHS-NIH11 · PAR-25-226
Closes Nov 19, 2026